Researchers have found that cancer cells evade destruction by macrophages in two ways — by converting cells to become docile, M2 macrophages, and by sending out an ‘eat me not’ signal that tricks M1 macrophages into letting them be. Investigators have developed a therapeutic that delivers a double whammy to knock out both mechanisms.